Graf Finckenstein Friedrich Insider Trades

Insider Trading History

Track insider trading activity for Graf Finckenstein Friedrich. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $257k 58,750 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$318k 58,750 shares
$5.41
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $650k 148,477 shares
Last Trade
Mar 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 31,246 shares
$4.58
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $578k 131,957 shares
Last Trade
Mar 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$75.7k 16,520 shares
$4.58
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $274k 62,504 shares
Last Trade
Mar 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 31,246 shares
$4.58
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $154k 35,159 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.3k 8,790 shares
$3.79
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.8k 3,907 shares
$3.79
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $513k 117,231 shares
Last Trade
Mar 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$27k 7,122 shares
$3.79
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $545k 124,353 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$48.1k 12,697 shares
$3.79
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $17.1k 3,907 shares
Last Trade
Dec 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.34k 3,906 shares
$2.14
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $489k 111,656 shares
Last Trade
Dec 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.25k 1,984 shares
$2.14
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $498k 113,640 shares
Last Trade
Dec 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.34k 3,906 shares
$2.14
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $192k 43,949 shares
Last Trade
Dec 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.6k 8,789 shares
$2.23
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $500k 114,198 shares
Last Trade
Dec 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.6k 8,789 shares
$2.23
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $481k 109,734 shares
Last Trade
Dec 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.95k 4,464 shares
$2.23
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $490k 111,857 shares
Last Trade
Sep 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$27.8k 12,697 shares
$2.19
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $462k 105,409 shares
Last Trade
Sep 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.1k 6,448 shares
$2.19
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $463k 105,608 shares
Last Trade
Jun 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.3k 12,695 shares
$1.76
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $434k 99,160 shares
Last Trade
Jun 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.3k 6,448 shares
$1.76
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $411k 93,750 shares
Last Trade
Mar 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$380k 93,750 shares
$4.05
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $554k 126,383 shares
Last Trade
Mar 03, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$252k 62,497 shares
$4.04
$4.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up